Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001206570 | SCV001377883 | pathogenic | not provided | 2024-01-19 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 215 of the SLC12A3 protein (p.Leu215Pro). This variant is present in population databases (rs780594361, gnomAD 0.003%). This missense change has been observed in individuals with Gitelman syndrome (PMID: 9734597, 17329572, 21051746, 26121437). ClinVar contains an entry for this variant (Variation ID: 937539). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC12A3 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SLC12A3 function (PMID: 12039972, 15102966). For these reasons, this variant has been classified as Pathogenic. |
European Hospital Georges Pompidou Genetics Department, |
RCV001828656 | SCV002513794 | pathogenic | Familial hypokalemia-hypomagnesemia | 2022-04-27 | criteria provided, single submitter | clinical testing | ACMG criteria used:PS3, PS4, PM2, PM3, PP3, PP5 |
Fulgent Genetics, |
RCV001828656 | SCV002810913 | pathogenic | Familial hypokalemia-hypomagnesemia | 2024-02-26 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001828656 | SCV002089334 | pathogenic | Familial hypokalemia-hypomagnesemia | 2021-01-27 | no assertion criteria provided | clinical testing |